David R. Bauer
Lawyers
Filters
Tenaya Therapeutics $75 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Zoetis $1.35 billion senior notes offering
The investment-grade notes are due 2025 and 2032
Metalmark Capital up to $50 million investment in Morgenesis
We advised Metalmark on the transaction
Akoya Biosciences $50 million at-the-market program
The common stock is listed on the Nasdaq Global Select Market
Molded Devices acquisition of GlobalMed and Schauenburg-Truplast
We advised Molded Devices on the acquisition and the related financing arrangements
QUALCOMM $1.9 billion notes offering
The investment-grade notes are due 2033 and 2053
NextGen Healthcare $275 million convertible senior notes offering
The 3.75% convertible notes are due 2027
Prime Medicine $175 million IPO
The shares are listed on the Nasdaq Global Market
Denali Therapeutics $316 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
European Biotech Acquisition $200 million combination with Oculis
We are advising European Biotech Acquisition Corp. on its deSPAC transaction